Skip to content
  • Latest News
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Privacy Policy
  • Terms and Conditions
  • About Us
Archyde

Archyde

  • News
  • World
  • Economy
  • Technology
  • Health
  • Entertainment
  • Sport

semaglutide india

India’s GLP-1 Weight-Loss Drug Boom: Market Growth and Future Outlook

August 12, 2026 by Dr. Priya Deshmukh - Senior Editor, Health

India is facing a rapid rise in obesity and type 2 diabetes, with approximately 11% of Indian adults projected to be obese by 2035, according to the World Obesity Federation … Read More

Categories Health Tags diabetes and obesity, digital obesity care, endocrinology india, generic semaglutide india, glp-1 drugs india, glp-1 revolution india, glp-1 therapy, glp-1 weight loss drugs, healthcare innovation india, medical weight management, metabolic health, mounjaro india, obesity awareness india, obesity healthcare india, obesity management, obesity treatment india, ozempic india, saloni paliwal, semaglutide india, tirzepatide india, voy india, wegovy india, weight loss medicines india, weight loss treatment Leave a comment

Recent Posts

  • Foster Families Question Daycare Payments Amid DSS Coverage Pledge
  • Research Specialist IV – Eye Research in Seattle, WA
  • UK Citizen Science Project Tracks Declining Butterfly Populations
  • Will Smith Slap Champion Training Video
  • Lawyer Locates Heir for Small Inheritance After Parents’ Death
  • Latest News
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Privacy Policy
  • Terms and Conditions
  • About Us
© 2026 Archyde — All Rights Reserved. Contact | Privacy Policy